We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMP icon
376
Ameriprise Financial
AMP
$47.9B
$52K ﹤0.01%
+220
New +$58.9K
ETSY icon
377
Etsy
ETSY
$7.9B
$52K ﹤0.01%
716
– –
LEA icon
378
Lear
LEA
$7.16B
$52K ﹤0.01%
411
– –
GIB icon
379
CGI
GIB
$14.2B
$51K ﹤0.01%
640
+447
+232% +$36.1K
SNA icon
380
Snap-on
SNA
$21.5B
$51K ﹤0.01%
259
– –
BIO icon
381
Bio-Rad Laboratories Class A
BIO
$7.99B
$49K ﹤0.01%
98
– –
KIM icon
382
Kimco Realty
KIM
$17.7B
$49K ﹤0.01%
2,494
– –
XYL icon
383
Xylem
XYL
$29.8B
$48K ﹤0.01%
613
– –
JOYY
384
JOYY Inc
JOYY
$3.52B
$47K ﹤0.01%
1,564
-455
-23% -$16.7K
SLF icon
385
Sun Life Financial
SLF
$45.4B
$46K ﹤0.01%
997
– –
JBHT icon
386
JB Hunt Transport Services
JBHT
$27.5B
$45K ﹤0.01%
286
– –
BRO icon
387
Brown & Brown
BRO
$23.5B
$42K ﹤0.01%
+716
New +$43.9K
MU icon
388
Micron Technology
MU
$960B
$42K ﹤0.01%
758
– –
SBNY
389
DELISTED
Signature Bank
SBNY
$42K ﹤0.01%
234
+183
+359% +$41K
IQV icon
390
IQVIA
IQV
$34.8B
$41K ﹤0.01%
+188
New +$40.8K
FMC icon
391
FMC
FMC
$1.41B
$40K ﹤0.01%
376
– –
RPM icon
392
RPM International
RPM
$13.6B
$40K ﹤0.01%
513
– –
SSNC icon
393
SS&C Technologies
SSNC
$16.8B
$40K ﹤0.01%
+686
New +$44.1K
TTC icon
394
Toro Company
TTC
$9.02B
$40K ﹤0.01%
523
– –
WDC icon
395
Western Digital
WDC
$157B
$39K ﹤0.01%
1,159
– –
ENTG icon
396
Entegris
ENTG
$20.4B
$38K ﹤0.01%
+416
New +$45.1K
TAP icon
397
Molson Coors Class B
TAP
$7.93B
$38K ﹤0.01%
694
– –
SCI icon
398
Service Corp International
SCI
$11B
$35K ﹤0.01%
505
-488
-49% -$33.4K
PBA icon
399
Pembina Pipeline
PBA
$29.8B
$33K ﹤0.01%
933
– –
PXD
400
DELISTED
Pioneer Natural Resource Co.
PXD
$33K ﹤0.01%
149
-1,014
-87% -$257K
14 15
16
17 18

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.